Safe and efficacious prolonged use of an olive oil-based lipid emulsion (ClinOleic) in chronic intestinal failure

Clin Nutr. 2004 Aug;23(4):697-703. doi: 10.1016/j.clnu.2003.11.007.

Abstract

Background & aims: Injectable lipid emulsion is an important component of parenteral nutrition. ClinOleic is a lipid emulsion composed of olive oil (80%) and soybean oil (20%). This study evaluated the efficacy and safety of ClinOleic in adults already receiving parenteral nutrition, comparing it to their usual lipid (soybean-oil-based).

Methods: Thirteen adults dependent on home parenteral nutrition were recruited from a single hospital. ClinOleic was administered for 6 months. Two-monthly assessments were made. In addition, clinical and adverse events were recorded for 6-month periods before, during and after the study.

Results: Total numbers of important complications for the 6 months before, during and after the study were 13, 9 and 9, respectively. There were, respectively, 5, 3 and 2 line infections, and 2, 0 and 5 thrombotic episodes in the 3 periods. The numbers of unplanned admissions were, respectively, 8, 5 and 7, with in-patient days accounting for 3.4%, 1.5%, and 2.6% of feeding days, respectively. One patient died (pneumonia). One new case of cholecystolithiasis appeared.

Conclusion: ClinOleic may be used as a safe alternative to standard soybean-oil-based lipid emulsions.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Fat Emulsions, Intravenous / adverse effects
  • Fat Emulsions, Intravenous / chemistry
  • Fat Emulsions, Intravenous / pharmacology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Olive Oil
  • Parenteral Nutrition, Home / adverse effects
  • Parenteral Nutrition, Home / methods*
  • Plant Oils*
  • Prospective Studies
  • Retrospective Studies
  • Safety
  • Treatment Outcome

Substances

  • Fat Emulsions, Intravenous
  • Olive Oil
  • Plant Oils